This is achieved by adding fenofibrate to simvastatin.
疗效是通过将非诺贝特加入辛伐他汀里取得的。
The study also confirmed that adding fenofibrate to simvastatin did not result in any excess risk of myopathy (muscle problems), venous thrombosis or pancreatitis.
这项研究同样证实将非诺贝特加入辛伐他汀不会引起任何肌病(肌肉病变)，静脉血栓或胰脏炎等多余危害。
In all, 136 of about 11, 000 people taking Vytorin in the three trials have died of various kinds of cancer, compared with 95 out of 11, 000 who took placebo or simvastatin alone.
三个试验中，总共大约有11000个病人服用Vytorin，其中有136人死于各种癌症，而与之相对照的服用安慰剂或只用simvastatin的11000个病人中，只有95人死于癌症。
Objective: To improve synthetic route of simvastatin.
目的：合成降脂药辛伐他汀。
These limitations apply to ALL patients taking simvastatin.
这些限制适用于所有使用辛伐他汀的患者。
OBJECTIVE To study the dissolution rate in vitro of simvastatin pills.
目的探讨辛伐他汀滴丸的体外溶出速率。
Objective: To study the effects on lipid - lowing therapy of simvastatin.
前言：目的：探讨影响辛伐他汀降脂疗效的临床因素。
SEARCH also included data on muscle injury in patients taking simvastatin.
SEARCH同时包括患者服用辛伐他汀出现肌肉损伤的数据。
Both simvastatin and CDPC can relieve the damages of the brain in rats HIBD.
辛伐他汀和胞二磷胆碱可减轻新生大鼠hibd后脑组织损害。
The over expression could be blocked by arecoline, PPVP, DMHPPP and simvastatin.
槟榔碱、PPVP、DMHPPP和辛伐他汀可以减轻其过量表达。
Objective To examine the protective effects of simvastatin on articular cartilage in vitro.
目的探讨辛伐他汀对关节软骨的保护作用。
Conclusion simvastatin is effective in reducing lipid lowering and anti-inflammatory effect.
结论辛伐他汀具有有效的调脂及抗炎作用。
Objective To investigate the antineoplastic effect of simvastatin in mice with H22 liver cancer.
目的研究辛伐他汀对小鼠肝癌细胞H22抑瘤作用的影响。
Objective To discuss the val ue of simvastatin plus fenofibrate for the treatment of mixed hyperlipemia.
目的探讨辛伐他汀联合非诺贝特治疗混合性高脂血症的价值。
Objective To compare the stabilizing effects of Tongxinluo and simvastatin on vulnerable plaques in rabbits.
目的对比研究通心络与辛伐他汀对兔易损斑块的稳定作用。
Objective: To compare the lipid- regulating effects of simvastatin with various dose in patients with hyperlipidemia.
目的：比较不同剂量辛伐他汀对高脂血症患者的调脂作用。
Objective: To explore the effect of simvastatin on the left atrial dimension (LAD) of patients with atrial fibrillation.
目的：探讨辛伐他汀对心房颤动患者左房内径(LAD)的影响。
Objective To observe the influence of simvastatin on blood lipid and Creactive protein in patients with acute coronary syndrome.
目的：探讨早期应用辛伐他汀对急性冠脉综合征患者的血脂和C反应蛋白影响。
Objective To investigate the effects of simvastatin on cerebral injury induced by ischemia reperfusion in rats and the mechanisms.
目的探讨辛伐他汀抗大鼠脑缺血再灌注损伤的作用及机制。
Objective To investigate the influences of simvastatin on carotid artery Intima-media thickness (IMT) and carotid atherosclerotic plaque.
目的探讨辛伐他汀对颈动脉内膜-中膜厚度及颈动脉粥样硬化斑块的影响。
OBJECTIVE To investigate the effect of simvastatin on biochemical markers of bone formation in treating the patients with hyperlipidemia.
目的研究辛伐他汀治疗高脂血症对骨形成生化标志物的影响。
There was no significant change of vasodilation responding to nitroglycerin and brachial diameter in all groups after simvastatin therapy.
辛伐他汀治疗后肱动脉内径和肱动脉对硝酸甘油的反应均无显著改变。
AIM: To probe the efficacy of simvastatin for lowering lipidemia in diabetic nephropathy with hyperlipidemia and protecting renal function.
目的：探索辛伐他汀对糖尿病肾病高脂血症降血脂疗效和保护肾功能的作用。
Objectives To investigate the effects of different dosage of simvastatin on acute myocardial infarction with paroxysmal atrial fibrillation.
目的探讨不同剂量辛伐他汀治疗急性心肌梗死合并阵发性心房颤动心脏复律后的近期疗效。
However, no significant discrepancy was detected in the pharmacokinetics parameters of simvastatin and its main metabolite simvastatin aicd.
但是，辛伐他汀及其主要代谢产物辛伐他汀酸的药代动力学参数没有出现统计学上的差异。
Objective: to observe the effects of early simvastatin intervention on endothelial vasodilator function in patients with acute coronary syndrome (ACS).
目的：探讨急性冠脉综合征(ACS)患者早期应用辛伐他汀后血管内皮功能的变化及其临床意义。
Objective To investigate the effect of simvastatin, ticlopidin and aspirin on the plasma plasminogen activitor inhibitor-l(PAI-1) contents in CHD patients.
目的研究辛伐他汀、抵克立得、阿司匹林对冠心病（CHD）患者血浆PAI-1含量的影响。
The risk of myopathy is also increased when simvastatin, especially at the higher doses, is used with certain drugs (see Simvastatin Dose Limitations below).
当辛伐他汀（特别是大剂量）与某些药物联合服用时，也会增加肌病的风险。
The risk of myopathy is also increased when simvastatin, especially at the higher doses, is used with certain drugs (see Simvastatin Dose Limitations below).
当辛伐他汀（特别是大剂量）与某些药物联合服用时，也会增加肌病的风险。
应用推荐